Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

doi:10.1016/j.annonc.2024.05.537

Practice Guideline

. 2024 Aug;35(8):692-706.

doi: 10.1016/j.annonc.2024.05.537. Epub 2024 May 22.

Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

T Powles¹, L Albiges², A Bex³, E Comperat⁴, V Grünwald⁵, R Kanesvaran⁶, H Kitamura⁷, R McKay⁸, C Porta⁹, G Procopio¹⁰, M Schmidinger¹¹, C Suarez¹², J Teoh¹³, G de Velasco¹⁴, M Young¹⁵, S Gillessen¹⁶; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org

Affiliations

¹ Barts Cancer Institute, Department of Medical Oncology, Queen Mary University of London and Royal Free London NHS Foundation Trust, London, UK.
² Université Paris Saclay, Institut Gustave Roussy, Villejuif, France.
³ Specialist Centre for Kidney Cancer, Royal Free London NHS Foundation Trust, London; Division of Surgery and Interventional Science, University College London, London, UK; Department of Urology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
⁴ Department of Pathology, Medical University of Vienna, General Hospital of Vienna, Vienna, Austria.
⁵ Interdisciplinary Genitourinary Oncology, West German Cancer Center Clinic for Internal Medicine and Clinic for Urology, University Hospital Essen, Essen, Germany.
⁶ Division of Medical Oncology, National Cancer Centre, Singapore, Singapore.
⁷ Department of Urology, Faculty of Medicine, University of Toyama, Toyama, Japan.
⁸ Department of Medicine and Urology, University of California San Diego, La Jolla, USA.
⁹ Interdisciplinary Department of Medicine, University of Bari 'A. Moro', Bari; Division of Medical Oncology, A.O.U. Consorziale Policlinico di Bari, Bari.
¹⁰ Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
¹¹ Department of Urology, Medical University of Vienna, Vienna, Austria.
¹² Medical Oncology, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
¹³ S. H. Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Hong Kong SAR, China.
¹⁴ Instituto de Investigación i+12 and Departamento de Oncología Médica, Hospital University 12 de Octubre, Madrid, Spain.
¹⁵ Barts Cancer Institute, Department of Medical Oncology, Queen Mary University of London and Royal Free London NHS Foundation Trust, London, UK; Barts Cancer Institute, Department of Experimental Cancer Medicine, Queen Mary University of London, London, UK.
¹⁶ Oncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), Bellinzona; Università della Svizzera Italiana, Lugano, Switzerland.

PMID: 38788900
DOI: 10.1016/j.annonc.2024.05.537

Free article

Practice Guideline

Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

T Powles et al. Ann Oncol. 2024 Aug.

Free article

. 2024 Aug;35(8):692-706.

doi: 10.1016/j.annonc.2024.05.537. Epub 2024 May 22.

Authors

Affiliations

¹ Barts Cancer Institute, Department of Medical Oncology, Queen Mary University of London and Royal Free London NHS Foundation Trust, London, UK.
² Université Paris Saclay, Institut Gustave Roussy, Villejuif, France.
³ Specialist Centre for Kidney Cancer, Royal Free London NHS Foundation Trust, London; Division of Surgery and Interventional Science, University College London, London, UK; Department of Urology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
⁴ Department of Pathology, Medical University of Vienna, General Hospital of Vienna, Vienna, Austria.
⁵ Interdisciplinary Genitourinary Oncology, West German Cancer Center Clinic for Internal Medicine and Clinic for Urology, University Hospital Essen, Essen, Germany.
⁶ Division of Medical Oncology, National Cancer Centre, Singapore, Singapore.
⁷ Department of Urology, Faculty of Medicine, University of Toyama, Toyama, Japan.
⁸ Department of Medicine and Urology, University of California San Diego, La Jolla, USA.
⁹ Interdisciplinary Department of Medicine, University of Bari 'A. Moro', Bari; Division of Medical Oncology, A.O.U. Consorziale Policlinico di Bari, Bari.
¹⁰ Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
¹¹ Department of Urology, Medical University of Vienna, Vienna, Austria.
¹² Medical Oncology, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
¹³ S. H. Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Hong Kong SAR, China.
¹⁴ Instituto de Investigación i+12 and Departamento de Oncología Médica, Hospital University 12 de Octubre, Madrid, Spain.
¹⁵ Barts Cancer Institute, Department of Medical Oncology, Queen Mary University of London and Royal Free London NHS Foundation Trust, London, UK; Barts Cancer Institute, Department of Experimental Cancer Medicine, Queen Mary University of London, London, UK.
¹⁶ Oncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), Bellinzona; Università della Svizzera Italiana, Lugano, Switzerland.

PMID: 38788900
DOI: 10.1016/j.annonc.2024.05.537

No abstract available

Keywords: ESMO Clinical Practice Guideline (CPG); ESMO-MCBS; diagnosis; management; renal cell carcinoma; treatment.

PubMed Disclaimer

Cited by

Sunitinib in Patients with Metastatic Renal Cell Carcinoma with Favorable Risk: Be Aware of PD-L1 Expression.
Tsimafeyeu I. Tsimafeyeu I. Med Sci (Basel). 2024 Sep 13;12(3):48. doi: 10.3390/medsci12030048. Med Sci (Basel). 2024. PMID: 39311161 Free PMC article.
Potential of Metabolic MRI to Address Unmet Clinical Needs in Localised Kidney Cancer.
Horvat-Menih I, Stewart GD, Gallagher FA. Horvat-Menih I, et al. Cancers (Basel). 2025 May 26;17(11):1773. doi: 10.3390/cancers17111773. Cancers (Basel). 2025. PMID: 40507256 Free PMC article. Review.
Fruquintinib Plus Sintilimab in Patients with Treatment-Naive and Previously Treated Advanced Renal Cell Carcinoma: Results from a Phase Ib/II Clinical Trial.
Xu H, Yao X, He Z, Luo H, Li G, Guo J, Diao L, Fan Y, Li Y, Fan J, Hu X, Lu P, Shi H, Chen K, Tan P, Fan S, Shi M, Su W, Ye D. Xu H, et al. Target Oncol. 2025 Jan;20(1):113-125. doi: 10.1007/s11523-024-01120-6. Epub 2025 Jan 13. Target Oncol. 2025. PMID: 39806128 Clinical Trial.
Competing risk of death in patients with low, intermediate and high risk of recurrence after radical surgery for clear cell renal cell carcinoma.
Brännbäck A, Mustonen I, Laajala TD, Vainio P, Lindskog M, Kjellman A, Lundgren PO, Jaakkola PM, Mattila KE. Brännbäck A, et al. BJUI Compass. 2025 Jul 21;6(7):e70047. doi: 10.1002/bco2.70047. eCollection 2025 Jul. BJUI Compass. 2025. PMID: 40698356 Free PMC article.
Angiogenic and immune predictors of neoadjuvant axitinib response in renal cell carcinoma with venous tumour thrombus.
Wray R, Paverd H, Machado I, Barbieri J, Easita F, Edwards AR, Gallagher FA, Mendichovszky IA, Mitchell TJ, de la Roche M, Shields JD, Ursprung S, Wallis L, Warren AY, Welsh SJ, Crispin-Ortuzar M, Stewart GD, Jones JO; NAXIVA Study Group. Wray R, et al. Nat Commun. 2025 Apr 28;16(1):3870. doi: 10.1038/s41467-025-58436-8. Nat Commun. 2025. PMID: 40295487 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Affiliations

Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Authors

Affiliations

Similar articles

Cited by

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical

Similar articles

Cited by

Publication types

MeSH terms

Related information

LinkOut - more resources

Full Text Sources

Medical